133 related articles for article (PubMed ID: 31462069)
1. Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?
Pitre LD; Linford G; Pond GR; McWhirter E; Seow H
J Cutan Med Surg; 2019; 23(6):586-594. PubMed ID: 31462069
[TBL] [Abstract][Full Text] [Related]
2. Association between dermatology follow-up and melanoma survival: A population-based cohort study.
Huang Y; Fleming P; Fung K; Chan AW
J Am Acad Dermatol; 2024 Jun; 90(6):1161-1169. PubMed ID: 38368952
[TBL] [Abstract][Full Text] [Related]
3. Melanoma prognosis in the United States: Identifying barriers for improved care.
Hopkins ZH; Moreno C; Carlisle R; Secrest AM
J Am Acad Dermatol; 2019 May; 80(5):1256-1262. PubMed ID: 30659870
[TBL] [Abstract][Full Text] [Related]
4. Incidence Rates and Outcomes of Nodular and Superficial Spreading Melanoma along the Rural-Urban Continuum in Kentucky and Their Relationship to Provider Care Access.
McElroy D; Towery M; Molina-Lopez S; Eastham R; Alexander SG; Mountjoy NJ
South Med J; 2024 May; 117(5):235-240. PubMed ID: 38701843
[TBL] [Abstract][Full Text] [Related]
5. Impact of rurality on processes and outcomes in melanoma care: results from a whole-Scotland melanoma cohort in primary and secondary care.
Murchie P; Adam R; Khor WL; Raja EA; Iversen L; Brewster DH; Lee AJ
Br J Gen Pract; 2018 Aug; 68(673):e566-e575. PubMed ID: 29914883
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic status influences care of patients with acne in Ontario, Canada.
Haider A; Mamdani M; Shaw JC; Alter DA; Shear NH
J Am Acad Dermatol; 2006 Feb; 54(2):331-5. PubMed ID: 16443069
[TBL] [Abstract][Full Text] [Related]
7. The influence of dermatologist and primary care physician visits on melanoma outcomes among Medicare beneficiaries.
Roetzheim RG; Lee JH; Ferrante JM; Gonzalez EC; Chen R; Fisher KJ; Love-Jackson K; McCarthy EP
J Am Board Fam Med; 2013; 26(6):637-47. PubMed ID: 24204060
[TBL] [Abstract][Full Text] [Related]
8. Brief Report: Increase in Melanoma Incidence in Ontario.
Langley A; Levesque L; Baetz T; Asai Y
J Cutan Med Surg; 2018; 22(5):476-478. PubMed ID: 29716393
[TBL] [Abstract][Full Text] [Related]
9. Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care.
Look Hong NJ; Cheng SY; Baxter NN; Wright FC
J Surg Oncol; 2018 Mar; 117(4):597-617. PubMed ID: 29228470
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic status as a predictor of melanoma survival in a series of 1083 cases from Brazil: just a marker of health services accessibility?
Quintella Mendes GL; Koifman S
Melanoma Res; 2013 Jun; 23(3):199-205. PubMed ID: 23442344
[TBL] [Abstract][Full Text] [Related]
11. The association of physician-specialty density and melanoma prognosis in the United States, 1988 to 1993.
Eide MJ; Weinstock MA; Clark MA
J Am Acad Dermatol; 2009 Jan; 60(1):51-8. PubMed ID: 18937998
[TBL] [Abstract][Full Text] [Related]
12. Rural Residency Status in South Dakotans is Not Associated With More Advanced Stage Melanoma at Time of Diagnosis.
Newton J
S D Med; 2023 Sep; 76(9):401. PubMed ID: 37738489
[TBL] [Abstract][Full Text] [Related]
13. Distance to diagnosing provider as a measure of access for patients with melanoma.
Stitzenberg KB; Thomas NE; Dalton K; Brier SE; Ollila DW; Berwick M; Mattingly D; Millikan RC
Arch Dermatol; 2007 Aug; 143(8):991-8. PubMed ID: 17709657
[TBL] [Abstract][Full Text] [Related]
14. The association of Medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma.
Kirsner RS; Wilkinson JD; Ma F; Pacheco H; Federman DG
Arch Dermatol; 2005 Jun; 141(6):753-7. PubMed ID: 15967922
[TBL] [Abstract][Full Text] [Related]
15. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
Amini A; Rusthoven CG; Waxweiler TV; Jones BL; Fisher CM; Karam SD; Raben D
J Am Acad Dermatol; 2016 Feb; 74(2):309-16. PubMed ID: 26670715
[TBL] [Abstract][Full Text] [Related]
16. The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France.
Durbec F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Domissy-Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A; Grange F
Arch Dermatol; 2010 Mar; 146(3):240-6. PubMed ID: 20231493
[TBL] [Abstract][Full Text] [Related]
17. Low level of education is associated with later stage at diagnosis and reduced survival in cutaneous malignant melanoma: a nationwide population-based study in Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Wagenius G; Carstensen J; Hansson J
Eur J Cancer; 2013 Aug; 49(12):2705-16. PubMed ID: 23583439
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.
Bedikian AY; Wei C; Detry M; Kim KB; Papadopoulos NE; Hwu WJ; Homsi J; Davies M; McIntyre S; Hwu P
Am J Clin Oncol; 2011 Dec; 34(6):603-10. PubMed ID: 21150567
[TBL] [Abstract][Full Text] [Related]
19. Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from Sweden.
Eriksson H; Lyth J; Månsson-Brahme E; Frohm-Nilsson M; Ingvar C; Lindholm C; Naredi P; Stierner U; Carstensen J; Hansson J
J Clin Oncol; 2014 May; 32(13):1356-64. PubMed ID: 24687828
[TBL] [Abstract][Full Text] [Related]
20. Late-Stage Melanoma in New York State: Associations with Socioeconomic Factors and Healthcare Access at the County Level.
Shah P; Shao Y; Geller AC; Polsky D
J Invest Dermatol; 2021 Jul; 141(7):1699-1706.e7. PubMed ID: 33516743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
